ARIA‐suggested drugs for allergic rhinitis: what impact on quality of life? A GA2LEN Review
Open Access
- 25 April 2008
- Vol. 63 (6) , 660-669
- https://doi.org/10.1111/j.1398-9995.2008.01649.x
Abstract
Allergic diseases constitute a global health problem, as they have an increasing economic and social impact and, especially, they can deeply interfere with the patients’ daily life, being a cause of physical and emotional discomfort. This is why the health‐related quality‐of‐life (HRQoL) has become increasingly important in health care research; in fact, the assessment of the impact the disease and its treatment have on patients, provides a more comprehensive approach in outcome evaluation. Numerous validated questionnaires are available and many studies have been performed evaluating HRQoL in people affected by allergic rhinitis (AR), thus testifying a great interest in this topic. The aims of the present review are: to examine the scientific literature of the last 3 years dealing with the impact of AR treatments suggested by allergic rhinitis and its impact on asthma guidelines on patients’ QoL, and to identify the unexplored or not‐fully‐investigated areas concerning this issue.Keywords
This publication has 43 references indexed in Scilit:
- Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitisAnnals of Allergy, Asthma & Immunology, 2006
- Effect of desloratadine therapy on symptom scores and measures of nasal patency in seasonal allergic rhinitis: results of a single-center, placebo-controlled trialAnnals of Allergy, Asthma & Immunology, 2006
- Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitisAnnals of Allergy, Asthma & Immunology, 2005
- Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitisAnnals of Allergy, Asthma & Immunology, 2005
- Effects of adjuvant therapy with 0.1% olopatadine hydrochloride ophthalmic solution on quality of life in patients with allergic rhinitis using systemic or nasal therapyAnnals of Allergy, Asthma & Immunology, 2005
- Efficacy and safety of levocetirizine on symptoms and health-related quality of life of children with perennial allergic rhinitis: a double-blind, placebo-controlled randomized clinical trialAnnals of Allergy, Asthma & Immunology, 2005
- Increased Nasal Airflow With Budesonide Compared With Desloratadine During the Allergy SeasonJAMA Otolaryngology–Head & Neck Surgery, 2005
- Comparison of the effects of fluticasone propionate aqueous nasal spray and loratadine on daytime alertness and performance in children with seasonal allergic rhinitisAnnals of Allergy, Asthma & Immunology, 2004
- Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitisAnnals of Allergy, Asthma & Immunology, 2004
- Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitisAnnals of Allergy, Asthma & Immunology, 1999